{"id":23359,"date":"2022-12-25T06:45:47","date_gmt":"2022-12-25T06:45:47","guid":{"rendered":"https:\/\/dailytalks.org\/?p=23359"},"modified":"2022-12-25T06:45:47","modified_gmt":"2022-12-25T06:45:47","slug":"nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=23359","title":{"rendered":"Nova Mentis receives Health Canada approval for psilocybin clinical trial"},"content":{"rendered":"<p>VANCOUVER \u2013 Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders\u00a0 announced that the company has received a No Objection Letter from Health Canada, allowing NOVA to proceed with the first-ever Phase II A clinical trial assessing&#8230;<br \/><a href=\"https:\/\/www.canadianinvestor.com\/2022\/12\/22\/nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER \u2013 Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology<\/p>\n","protected":false},"author":1,"featured_media":23360,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[],"class_list":["post-23359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",0,0,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/12\/23359-nova-mentis-receives-health-canada-approval-for-psilocybin-clinical-trial.jpg",1,1,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=43\" rel=\"category\">Health<\/a>","tag_info":"Health","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/23359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23359"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/23359\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/23360"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}